NVS

#43
Novartis AG
151.1 6 USD
-0.22%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
150.96
152.03
Range Annuel
112.38
170.46
Changement quotidien
-0.22%
Changement Mensuel
+3.17%
Evolution sur 6 mois
+15.37%
Changement Annuel
+31.44%
Clôture Précédente
151.5 0
Open
151.7 6
Low
150.9 6
High
152.0 3
Volume
339
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 288.44 B
  • Employee 75 K
  • Founded 1996
  • CEO Vasant Narasimhan
  • Website www.novartis.com
  • Headquarter Switzerland
  • FIGI BBG000LYF3S8
  • Industry Fabricants de Médicaments — Généralités
Chiffre d'affaires total
Résultat net
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie

Novartis AG

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.

Nouvelles